Decreased expression of FcγRII in active Graves' disease patients-Reference-Cited by-同舟云学术

Decreased expression of FcγRII in active Graves' disease patients

Published:2019-04-29 Issue:6 Volume:33 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:J Clin Lab Anal

Author:

Lu Xixuan¹^ORCID,Peng Shiqiao¹,Wang Xinyi²,Shan Zhongyan¹,Teng Weiping¹

Affiliation:

1. Department of Endocrinology and Metabolism, Institute of Endocrinology, Liaoning Provincial Key Laboratory of Endocrine Diseases The First Affiliated Hospital of China Medical University Shenyang China

2. Department of Laboratory Medicine The First Affiliated Hospital of China Medical University Shenyang China

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.22904

Reference29 articles.

1. Autoimmune thyroid disorders

2. Is Graves’ disease a primary immunodeficiency? New immunological perspectives on an endocrine disease

3. Genetic and epigenetic mechanisms in thyroid autoimmunity

4. Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases

5. Control of Cytokine Production by Human Fc Gamma Receptors: Implications for Pathogen Defense and Autoimmunity

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aberrant expression of inhibitory receptors on B cells in patients with Graves’ disease;Human Immunology;2022-02

2. Immunological Drivers in Graves' Disease: NK Cells as a Master Switcher;Frontiers in Endocrinology;2020-07-17

3. CD32a polymorphism rs1801274 affects the risk of Kawasaki disease;Artificial Cells, Nanomedicine, and Biotechnology;2020-01-01